These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 8423936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
    Kinne RW, Schemer K, Behr T, Sharkey RM, Palombokinne E, Emmrich F, Goldenberg DM, Wolf F, Becker W.
    Nucl Med Commun; 1999 Jan; 20(1):67-75. PubMed ID: 9949415
    [Abstract] [Full Text] [Related]

  • 5. Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab' in patients suspected of ovarian cancer.
    Tibben JG, Massuger LF, Claessens RA, Schijf CP, Pak KY, Strijk SP, Kenemans P, Corstens FH.
    Nucl Med Commun; 1992 Dec; 13(12):885-93. PubMed ID: 1465272
    [Abstract] [Full Text] [Related]

  • 6. Imaging lung cancer by scintigraphy with Indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5.
    Buccheri G, Biggi A, Ferrigno D, D'Angeli B, Vassallo G, Leone A, Taviani M, Comino A.
    Cancer; 1992 Aug 15; 70(4):749-59. PubMed ID: 1643607
    [Abstract] [Full Text] [Related]

  • 7. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM, Goldenberg H, Sharkey RM, Higginbotham-Ford E, Lee RE, Swayne LC, Burger KA, Tsai D, Horowitz JA, Hall TC.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [Abstract] [Full Text] [Related]

  • 8. Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.
    Vuillez JP, Moro D, Brambilla E, Brichon PY, Ferretti G, Saccavini JC, Brambilla C.
    Eur J Cancer; 1994 Feb 01; 30A(8):1089-92. PubMed ID: 7654435
    [Abstract] [Full Text] [Related]

  • 9. Radioimmunoscintigraphy with 111In labelled monoclonal antibody fragments (F(ab')2 BW 431/31) against CEA: radiolabelling, antibody kinetics and distribution, findings in tumour and non-tumour patients.
    Bares R, Fass J, Truong S, Buell U, Schumpelick V.
    Nucl Med Commun; 1989 Sep 01; 10(9):627-41. PubMed ID: 2616103
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
    Behr TM, Becker WS, Klein MW, Bair HJ, Scheele JR, Wolf FG.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
    Peters AM, Roddie ME, Danpure HJ, Osman S, Zacharopoulos GP, George P, Stuttle AW, Lavender JP.
    Nucl Med Commun; 1988 Jun 01; 9(6):449-63. PubMed ID: 3412733
    [Abstract] [Full Text] [Related]

  • 15. Imaging of medullary carcinoma of the thyroid using 111In-labelled anti-CEA monoclonal antibody fragments.
    O'Byrne KJ, Hamilton D, Robinson I, Sweeney E, Freyne PJ, Cullen MJ.
    Nucl Med Commun; 1992 Mar 01; 13(3):142-8. PubMed ID: 1557212
    [Abstract] [Full Text] [Related]

  • 16. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
    Moffat FL, Vargas-Cuba RD, Serafini AN, Casillas VJ, Morillo G, Benedetto P, Robinson DS, Ardalan B, Manten HD, Clark KC.
    Cancer; 1994 Feb 01; 73(3 Suppl):836-45. PubMed ID: 8306268
    [Abstract] [Full Text] [Related]

  • 17. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
    Behr T, Becker W, Hannappel E, Wolf F.
    Nucl Med Commun; 1994 Nov 01; 15(11):865-70. PubMed ID: 7870392
    [Abstract] [Full Text] [Related]

  • 18. Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate.
    Petrov AD, Narula J, Nakazawa A, Pak KY, Khaw BA.
    Nucl Med Commun; 1997 Mar 01; 18(3):241-51. PubMed ID: 9106778
    [Abstract] [Full Text] [Related]

  • 19. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
    Casey JL, King DJ, Chaplin LC, Haines AM, Pedley RB, Mountain A, Yarranton GT, Begent RH.
    Br J Cancer; 1996 Nov 01; 74(9):1397-405. PubMed ID: 8912535
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.